HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 47,000
+4,550 (10.72%)
At close: Jun 12, 2026
HEM Pharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Net Income | -25,608 | -23,842 | -7,646 |
Depreciation & Amortization | 2,695 | 2,595 | 2,422 |
Loss (Gain) From Sale of Assets | 3.47 | 7.02 | - |
Asset Writedown & Restructuring Costs | 534.93 | 534.93 | - |
Loss (Gain) From Sale of Investments | -27.19 | -30.47 | -24.89 |
Stock-Based Compensation | 877.73 | 929.21 | 915.56 |
Provision & Write-off of Bad Debts | 0.15 | 0.14 | - |
Other Operating Activities | 8,031 | 7,814 | 418.39 |
Change in Accounts Receivable | 905.63 | 2,708 | -2,568 |
Change in Inventory | 96.83 | -504.96 | -781.57 |
Change in Accounts Payable | 468.97 | 410.61 | 549.43 |
Change in Other Net Operating Assets | 5,288 | 1,033 | -964.77 |
Operating Cash Flow | -6,733 | -8,345 | -7,680 |
Capital Expenditures | -11,054 | -9,755 | -4,687 |
Sale of Property, Plant & Equipment | 0.18 | 16.18 | - |
Cash Acquisitions | -106.19 | -106.19 | - |
Sale (Purchase) of Intangibles | -314.8 | -229.87 | -110.97 |
Investment in Securities | 3,677 | 4,504 | -4,675 |
Other Investing Activities | -0 | -0 | - |
Investing Cash Flow | -7,827 | -5,571 | -9,473 |
Short-Term Debt Issued | - | 1,400 | - |
Long-Term Debt Issued | - | 19,218 | - |
Total Debt Issued | 18,796 | 20,618 | - |
Long-Term Debt Repaid | - | -890.94 | -324.36 |
Net Debt Issued (Repaid) | 17,857 | 19,727 | -324.36 |
Issuance of Common Stock | 1,691 | 1,707 | 16,512 |
Other Financing Activities | -6.94 | -8.06 | -915.47 |
Financing Cash Flow | 19,541 | 21,425 | 15,272 |
Foreign Exchange Rate Adjustments | 129.2 | 1.31 | 3.91 |
Miscellaneous Cash Flow Adjustments | - | - | -0 |
Net Cash Flow | 5,110 | 7,511 | -1,877 |
Free Cash Flow | -17,787 | -18,100 | -12,367 |
Free Cash Flow Margin | -123.42% | -139.45% | -82.08% |
Free Cash Flow Per Share | -2501.38 | -2572.96 | -1945.77 |
Cash Interest Paid | 434.39 | 418.68 | 258.79 |
Cash Income Tax Paid | 22.81 | 20.7 | -22.47 |
Levered Free Cash Flow | 5,017 | 4,409 | - |
Unlevered Free Cash Flow | 5,622 | 4,814 | - |
Change in Working Capital | 6,759 | 3,647 | -3,765 |